CHS INC - CHSINC 8 PERP (CHSCP) Fundamental Analysis & Valuation

NASDAQ:CHSCP • US12542R2094

Current stock price

27.65 USD
+0.04 (+0.14%)
Last:

This CHSCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CHSCP Profitability Analysis

1.1 Basic Checks

  • CHSCP had a positive operating cash flow in the past year.
  • In the past 5 years CHSCP has always been profitable.
  • In the past 5 years CHSCP always reported a positive cash flow from operatings.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • CHSCP has a Return On Assets (2.96%) which is in line with its industry peers.
  • CHSCP has a Return On Equity (5.48%) which is in line with its industry peers.
  • CHSCP has a Return On Invested Capital (0.37%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHSCP is below the industry average of 6.78%.
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROIC 0.37%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a Profit Margin value of 1.75%, CHSCP perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
  • CHSCP's Profit Margin has improved in the last couple of years.
  • CHSCP has a Operating Margin of 0.21%. This is in the lower half of the industry: CHSCP underperforms 62.07% of its industry peers.
  • In the last couple of years the Operating Margin of CHSCP has declined.
  • CHSCP has a worse Gross Margin (3.21%) than 83.91% of its industry peers.
  • In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
Industry RankSector Rank
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. CHSCP Health Analysis

2.1 Basic Checks

  • CHSCP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CHSCP has a worse debt/assets ratio than last year.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • CHSCP has an Altman-Z score of 2.11. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CHSCP (2.11) is comparable to the rest of the industry.
  • CHSCP has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.32, CHSCP is in the better half of the industry, outperforming 60.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACC0.07
WACC5.56%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCP has a Current Ratio of 1.42. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
  • CHSCP has a Current ratio (1.42) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.80 indicates that CHSCP may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.80, CHSCP perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.8
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. CHSCP Growth Analysis

3.1 Past

  • The Revenue has decreased by -5.74% in the past year.
  • Measured over the past years, CHSCP shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. CHSCP Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 93.10% of the companies in the same industry are more expensive than CHSCP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.4
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. CHSCP Dividend Analysis

5.1 Amount

  • CHSCP has a Yearly Dividend Yield of 7.26%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.22, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 94.25% of the companies listed in the same industry.
  • CHSCP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 7.26%

5.2 History

  • CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
  • CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years22
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CHSCP pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHSCP Fundamentals: All Metrics, Ratios and Statistics

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (4/23/2026, 11:04:40 AM)

27.65

+0.04 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-15
Earnings (Next)07-07
Inst Owners11.07%
Inst Owner Change-0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap339.27M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio1.45
Dividend
Industry RankSector Rank
Dividend Yield 7.26%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years22
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.57
P/B 0.03
P/tB 0.03
EV/EBITDA 2.4
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY174.49%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROCE 0.54%
ROIC 0.37%
ROICexc 0.38%
ROICexgc 0.38%
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 96.64%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 79.1%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.8
Altman-Z 2.11
F-Score4
WACC5.56%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 8 PERP / CHSCP Fundamental Analysis FAQ

What is the fundamental rating for CHSCP stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.


What is the valuation status of CHS INC - CHSINC 8 PERP (CHSCP) stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.


What is the profitability of CHSCP stock?

CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 4 / 10.


How financially healthy is CHS INC - CHSINC 8 PERP?

The financial health rating of CHS INC - CHSINC 8 PERP (CHSCP) is 3 / 10.


Can you provide the dividend sustainability for CHSCP stock?

The dividend rating of CHS INC - CHSINC 8 PERP (CHSCP) is 8 / 10 and the dividend payout ratio is 27.52%.